South Korea Anti-hypertensive Drugs Market Size, Share, and COVID-19 Impact Analysis, By Product (ACE Inhibitors (ACEIs), Angiotensin II Receptor Blockers (ARBs), Direct Renin Inhibitors, Calcium Channel Blockers, Diuretics, Mineralocorticoid Receptor Antagonists (MRAs), Beta-blockers, Alpha-1 Blockers, Central Alpha-2 Agonists, Direct Vasodilators, Fixed-dose Combinations (FDCs), and Others), By Type (Standard Hypertension, Treatment-resistant Hypertension, and Hypertensive Emergency/ Urgency), and South Korea Anti-hypertensive Drugs Market Insights, Industry Trend, Forecasts to 2035.
Premium Report Details
Base Year:
2024
Tables & Figures:
130
Pages:
240
Countries covered:
20
Companies covered::
18
Forecast CAGR:
CAGR of 4.76%
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies